Table 2. Overall survival and disease-free survival in 123 patients with adenocarcinoma.

	No.	5-year survival	Log-rank	RFS at 36  (months)a	Log-rank
	(%)	(%)	P-value	(%)	P-value
Age
≦48	67 (54)	84	0.091	85	0.017
>48	56 (46)	77		80
FIGO stage
IB	96 (78)	86	0.004	89	0.001
IIA	5 (4)	53		60
IIB	22 (18)	59		59
Tumour size (mm)
≦20	37 (30)	95	<0.001	97	<0.001
21–40	46 (37)	91		91
>40	40 (33)	55		59
Depth in cervical wall
<1/3	34 (28)	97	0.004	100	0.001
1/3–2/3	31 (25)	87		87
>2/3	58 (47)	67		87
Number of positive nodes
None	91 (74)	91	<0.001	93	<0.001
1–4	25 (20)	60		63
≧5	7 (6)	14		14
LVS invasion b
None	53 (43)	98	<0.001	98	<0.001
Few	32 (26)	81		84
Several	27 (22)	56		61
Many	11 (9)	55		55
Parametrial invasion
Negative	102 (83)	89	<0.001	92	<0.001
Positive	21 (17)	38		43
Infiltration to vagina
No	94 (76)	87	<0.001	89	<0.001
Yes	29 (24)	61		62
Ovarian metastases
Negative	94 (95)	84	<0.001	85	<0.001
Positive	6 (5)	17		20
Histological subtype
Mucinous	73 (59)	75	0.543	78	0.180
Endometrioid	50 (41)	88		90
Histological grade
Grade 1	86 (70)	85	<0.001	86	<0.001
Grade 2	23 (19)	87		86
Grade 3	14 (11)	47		56

FIGO=the International Federation of Gynecology and Obstetrics; LVS=lymph–vascular space; RFS=relapse-free survival.

^aRFS at 36 months.

^bLVS invasion.